IP Library Granted Patent US 7,994,217
Granted Patent B2
US 7,994,217 · App. 10/375,600 · Granted Aug 9, 2011

Prenatal multivitamin/multimineral supplement

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,994,217
App. No.
10/375,600
Granted
Aug 9, 2011
Kind
B2
Abstract

Multivitamin/Multimineral supplements are provided for supplementing iron and desirable nutrients in the diet of mammals. The supplements include an iron-amino acid chelate, a form of iron more bioavailable than traditional iron salts. The supplements may further include a pharmaceutically accepted salt form of iron as well as other nutritional vitamins and minerals. The supplements are useful for providing iron for pregnant and lactating females as well as for persons suffering from anemia.

Claims (165)

1. A composition suitable for administration to a pregnant or lactating female, the composition consisting of:

bioavailable iron in a form of at least one iron-amino acid chelate and a pharmaceutically acceptable salt;

a combination of vitamins or pharmaceutically acceptable salts thereof, the combination consisting of:

vitamin A in a weight of up to about 15 mg;

vitamin B1 in a weight range from about 0.5 mg to about 50 mg;

vitamin B2 in a weight range from about 0.5 mg to about 50 mg;

vitamin B6 in a weight range from about 0.1 mg to about 200 mg;

vitamin B12 in a weight range from about 2 mcg to about 250 mcg;

niacinamide in a weight range from about 1 mg to about 100 mg;

folic acid in a weight range from about 0.01 mg to about 5 mg;

vitamin C in a weight range from about 10 mg to about 1000 mg;

vitamin D in a weight range from about 0.001 mg to about 0.6 mg; and

vitamin E in a weight range from about 1 mg to about 125 mg;

a combination of minerals or pharmaceutically acceptable salts thereof, the combination consisting of:

calcium in a weight range from about 10 mg to about 2000 mg;

copper in a weight of up to about 10 mg;

zinc in a weight range from about 5 mg to about 100 mg; and

magnesium in a weight of up to about 400 mg; and

excipients that provide physical properties to the composition and allow delivery of the composition to a pregnant or lactating female as a pill, a tablet, a caplet, or a capsule.

2. The composition of claim 1 wherein the iron-amino acid chelate consists of an iron chelated to at least one amino acid.

3. The composition of claim 2 wherein the at least one amino acid is selected from the group consisting of alanine, arginine, asparagine, aspartic acid, cysteine, cystine, glutamine, glutamic acid, glycine, histidine, hydroxyproline, isoleucine, lysine, leucine, methionine, ornithine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, valine, and combinations thereof.

4. The composition of claim 1 wherein the iron-amino acid chelate is ferrous bis-glycinate chelate.

5. The composition of claim 1 wherein the pharmaceutically acceptable salt form of iron is selected from the group consisting of ferrous fumarate, ferrous sulfate, ferrous succinate, ferrous gluconate, ferrous lactate, ferrous tartarate, ferrous citrate, and combinations thereof.

6. The composition of claim 1 wherein the iron has a total weight in a range from about 5 mg to about 200 mg in the composition.

7. The composition of claim 6 wherein the pharmaceutically acceptable salt form of iron is from about 25% to about 75% of the total weight of the iron in the composition.

8. The composition of claim 6 wherein the iron-amino acid chelate is at least about 25% of the total weight of the iron in the composition.

9. The composition of claim 6 wherein the iron-amino acid chelate is at least about 75% of the total weight of the iron in the composition.

10. The composition of claim 1 wherein the iron-amino acid chelate is at least about 90% of the total weight of the iron in the composition.

11. A multivitamin/multimineral supplement suitable for administration to a pregnant or lactating female, the multivitamin/multimineral supplement consisting of:

bioavailable iron in a form consisting of at least one iron-amino acid chelate and a pharmaceutically acceptable salt; and

a multivitamin/multimineral component consisting of:

a combination of vitamins or pharmaceutically acceptable salts thereof, the combination consisting of:

vitamin A in a weight of up to about 15 mg;

vitamin B1 in a weight range from about 0.5 mg to about 50 mg;

vitamin B2 in a weight range from about 0.5 mg to about 50 mg;

vitamin B6 in a weight range from about 0.1 mg to about 200 mg;

vitamin B12 in a weight range from about 2 mcg to about 250 mcg;

niacinamide in a weight range from about 1 mg to about 100 mg;

folic acid in a weight range from about 0.01 mg to about 5 mg;

vitamin C in a weight range from about 10 mg to about 1000 mg;

vitamin D in a weight range from about 0.001 mg to about 0.6 mg; and

vitamin E in a weight range from about 1 mg to about 125 mg; and

a combination of minerals or pharmaceutically acceptable salts thereof, the combination consisting of:

calcium in a weight range from about 10 mg to about 2000 mg;

copper in a weight of up to about 10 mg;

zinc in a weight range from about 5 mg to about 100 mg; and

magnesium in a weight of up to about 400 mg; and

wherein the supplement is in a single dosage formulation selected from the group consisting of a pill, a tablet, a caplet, and a capsule.

12. The supplement of claim 11 wherein the iron-amino acid chelate consists of at least one molecule of iron chelated to at least one amino acid.

13. The supplement of claim 11 wherein the iron-amino acid chelate is ferrous bis-glycinate chelate.

14. The supplement of claim 11 wherein the iron-amino acid chelate has a weight in the range from about 10 mg to about 200 mg.

15. The supplement of claim 11 wherein the pharmaceutically acceptable salt form of iron is selected from the group consisting of ferrous fumarate, ferrous sulfate, ferrous succinate, ferrous gluconate, ferrous lactate, ferrous tartarate, ferrous citrate, and combinations thereof.

16. The supplement of claim 11 wherein the pharmaceutically acceptable salt form of iron has a weight in the range from about 10 to about 200 mg.

17. The supplement of claim 16 wherein the pharmaceutically acceptable salt form of iron is ferrous fumarate.

18. The supplement of claim 11 wherein the iron is in an amount that allows the supplement to be administered once-a-day.

19. A method for supplementing iron to a pregnant or lactating female, the method comprising administering to the pregnant or lactating female a composition consisting of:

bioavailable iron in a form of at least one iron-amino acid chelate and a pharmaceutically acceptable salt in combination with multivitamins and multiminerals; and

excipients that provide physical properties to the composition and allow delivery of the composition to a human as a pill, a tablet, a caplet, or a capsule; and

wherein the multivitamins and multiminerals consist of a combination of vitamins or pharmaceutically acceptable salts thereof consisting of:

vitamin A in a weight of up to about 15 mg;

vitamin B1 in a weight range from about 0.5 mg to about 50 mg;

vitamin B2 in a weight range from about 0.5 mg to about 50 mg;

vitamin B6 in a weight range from about 0.1 mg to about 200 mg;

vitamin B12 in a weight range from about 2 mcg to about 250 mcg;

niacinamide in a weight range from about 1 mg to about 100 mg;

folic acid in a weight range from about 0.01 mg to about 5 mg;

vitamin C in a weight range from about 10 mg to about 1000 mg;

vitamin D in a weight range from about 0.001 mg to about 0.6 mg; and

vitamin E in a weight range from about 1 mg to about 125 mg; and

a combination of minerals or pharmaceutically acceptable salts thereof consisting of:

calcium in a weight range from about 10 mg to about 2000 mg;

copper in a weight of up to about 10 mg;

zinc in a weight range from about 5 mg to about 100 mg; and

magnesium in a weight of up to about 400 mg.

20. The method of claim 19 wherein the iron-amino acid chelate administered consists of a molecule of iron chelated to at least one amino acid.

21. The method of claim 19 wherein the amino acid is selected from the group consisting of alanine, arginine, asparagine, aspartic acid, cysteine, cystine, glutamine, glutamic acid, glycine, histidine, hydroxyproline, isoleucine, lysine, leucine, methionine, ornithine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, valine, and combinations thereof.

22. The method of claim 19 wherein the iron-amino acid chelate is ferrous bis-glycinate chelate.

23. The method of claim 19 wherein the pharmaceutically acceptable salt form of iron is selected from the group consisting of ferrous fumarate, ferrous sulfate, ferrous succinate, ferrous gluconate, ferrous lactate, ferrous tartarate, ferrous citrate, and combinations thereof.

24. The method of claim 19 wherein the iron-amino acid chelate is:

ferrous bis-glycinate chelate in a weight range from about 10 mg to about 200 mg; and

wherein the pharmaceutically acceptable salt form of iron is ferrous fumarate in a weight range from about 10 mg to about 200 mg.

25. The method of claim 19 wherein the composition is administered for treating anemia in said female.

26. A method for supplementing iron in a pregnant or lactating female comprising administering a multivitamin/multimineral supplement to the pregnant or lactating female, in a pharmaceutically acceptable single dosage formulation chosen from a pill, a tablet, a caplet, and a capsule, the multivitamin/multimineral supplement consisting of:

iron in a form consisting of at least one iron-amino acid chelate and a pharmaceutically acceptable salt;

a combination of vitamins or pharmaceutically acceptable salts thereof consisting of:

vitamin A in a weight of up to about 15 mg;

vitamin B1 in a weight range from about 0.5 mg to about 50 mg;

vitamin B2 in a weight range from about 0.5 mg to about 50 mg;

vitamin B6 in a weight range from about 0.1 mg to about 200 mg;

vitamin B12 in a weight range from about 2 mcg to about 250 mcg;

niacinamide in a weight range from about 1 mg to about 100 mg;

folic acid in a weight range from about 0.01 mg to about 5 mg;

vitamin C in a weight range from about 10 mg to about 1000 mg;

vitamin D in a weight range from about 0.001 mg to about 0.6 mg; and

vitamin E in a weight range from about 1 mg to about 125 mg; and

a combination of minerals or pharmaceutically acceptable salts thereof consisting of:

calcium in a weight range from about 10 mg to about 2000 mg;

copper in a weight of up to about 10 mg;

zinc in a weight range from about 5 mg to about 100 mg; and

magnesium in a weight of up to about 400 mg.

27. The method of claim 26 wherein the iron-amino acid chelate provides at least about 75% of the total weight of the iron in the administered supplement.

28. The method of claim 26 wherein the iron-amino acid chelate provides at least about 90% of the total weight of the iron in the administered supplement.

29. The method of claim 26 wherein the iron-amino acid chelate is ferrous bis-glycinate chelate in a weight range from about 10 mg to about 200 mg.

30. The method of claim 26 wherein the supplement is administered for the treatment of anemia.

31. A method for reducing iron deficiency in a pregnant or lactating female comprising administering to the pregnant or lactating female, in a pharmaceutically acceptable single dosage formulation chosen from a pill, a tablet, a caplet, and a capsule, a composition consisting of:

bioavailable iron in a form of at least one iron-amino acid chelate and a pharmaceutically acceptable salt;

a combination of vitamins or pharmaceutically acceptable salts thereof consisting of:

vitamin A in a weight of up to about 15 mg;

vitamin B1 in a weight range from about 0.5 mg to about 50 mg;

vitamin B2 in a weight range from about 0.5 mg to about 50 mg;

vitamin B6 in a weight range from about 0.1 mg to about 200 mg;

vitamin B12 in a weight range from about 2 mcg to about 250 mcg;

niacinamide in a weight range from about 1 mg to about 100 mg;

folic acid in a weight range from about 0.01 mg to about 5 mg;

vitamin C in a weight range from about 10 mg to about 1000 mg;

vitamin D in a weight range from about 0.001 mg to about 0.6 mg; and

vitamin E in a weight range from about 1 mg to about 125 mg; and

a combination of minerals or pharmaceutically acceptable salts thereof consisting of:

calcium in a weight range from about 10 mg to about 2000 mg;

copper in a weight of up to about 10 mg;

zinc in a weight range from about 5 mg to about 100 mg; and

magnesium in a weight of up to about 400 mg.

32. The method of claim 31 wherein the iron-amino acid chelate is ferrous bis-glycinate chelate in a weight range from about 10 mg to about 200 mg.

33. The method of claim 31 wherein the folic acid has a weight in the range from about 0.01 mg to about 5 mg.

34. The method of claim 31 wherein the pregnant or lactating female is anemic.

35. A multivitamin, multimineral composition suitable for administration to a pregnant or lactating female consisting of:

bioavailable iron in a form of at least one iron-amino acid chelate and a pharmaceutically acceptable salt;

a combination of vitamins or pharmaceutically acceptable salts thereof consisting of:

vitamin A in a weight of up to about 15 mg;

vitamin B1 in a weight range from about 0.5 mg to about 50 mg;

vitamin B2 in a weight range from about 0.5 mg to about 50 mg;

vitamin B6 in a weight range from about 0.1 mg to about 200 mg;

vitamin B12 in a weight range from about 2 mcg to about 250 mcg;

niacinamide in a weight range from about 1 mg to about 100 mg;

folic acid in a weight range from about 0.01 mg to about 5 mg;

vitamin C in a weight range from about 10 mg to about 1000 mg;

vitamin D in a weight range from about 0.001 mg to about 0.6 mg; and

vitamin E in a weight range from about 1 mg to about 125 mg; and

a combination of minerals or pharmaceutically acceptable salts thereof consisting of:

calcium in a weight range from about 10 mg to about 2000 mg;

copper in a weight of up to about 10 mg;

zinc in a weight range from about 5 mg to about 100 mg; and

magnesium in a weight of up to about 400 mg; and

excipients that provide physical properties to the composition and allow delivery of the composition to a patient as a compressed tablet; and

wherein said composition does not include any further vitamins or pharmaceutically acceptable salts thereof, and wherein said composition does not include any further minerals or pharmaceutically acceptable salts thereof.

36. A multivitamin, multimineral composition suitable for administration to a pregnant or lactating female consisting of:

bioavailable iron in a form of at least one iron-amino acid chelate and a pharmaceutically acceptable salt;

a combination of vitamins or pharmaceutically acceptable salts thereof consisting of:

vitamin A in a weight of up to about 15 mg;

vitamin B1 in a weight range from about 0.5 mg to about 50 mg;

vitamin B2 in a weight range from about 0.5 mg to about 50 mg;

vitamin B6 in a weight range from about 0.1 mg to about 200 mg;

vitamin B12 in a weight range from about 2 mcg to about 250 mcg;

niacinamide in a weight range from about 1 mg to about 100 mg;

folic acid in a weight range from about 0.01 mg to about 5 mg;

vitamin C in a weight range from about 10 mg to about 1000 mg;

vitamin D in a weight range from about 0.001 mg to about 0.6 mg; and

vitamin E in a weight range from about 1 mg to about 125 mg;

a combination of minerals or pharmaceutically acceptable salts thereof consisting of:

calcium in a weight range from about 10 mg to about 2000 mg;

copper in a weight of up to about 10 mg;

zinc in a weight range from about 5 mg to about 100 mg; and

magnesium in a weight of up to about 400 mg;

excipients that provide physical properties to the composition, the composition being in the form of a coated compressed tablet; and

a disintegrant.

Assignments (2)
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Oct 24, 2011
From: SILVER POINT FINANCE, LLC
To: XANDODYNE PHARMACEUTICALS, INC.
Reel/Frame 027108/0381 →
SECURITY AGREEMENT Recorded Aug 2, 2005
From: XANODYNE PHARMACEUTICALS, INC.
To: SILVER POINT FINANCE, LLC, AS COLLATERAL AGENT
Reel/Frame 016334/0332 →